Despite established neuroprotective effects in ischemic stroke models, the therapeutic potential and molecular pathways of SPP1 in depression following intracerebral hemorrhage remain unexplored, warranting further investigation into its clinical applications for post‐ICH neuropsychiatric complications. Here, SPP1 is linked to depressive disorder.